• 134. ESMO 2024 - Lung Cancer with Dr Ned McNamee

  • Nov 2 2024
  • Length: 30 mins
  • Podcast

134. ESMO 2024 - Lung Cancer with Dr Ned McNamee

  • Summary

  • Lung cancer treatment has changed seismically since 2018 and the NEJM publication of Keynote 189. This week, we have Dr. Ned Mcnamee on the show to give us his highlights of lung cancer updates from ESMO 2024. He explores the resectable lung cancer space with Checkmate-77T; crosses the ADRIATIC trial in patients with limited-stage small cell lung cancer, and brings in a home run with an updated LAURA trial mention (osimertinib after definitive chemoradiotherapy)


    Links to studies discussed in this episode (subscription may be required):

    Checkmate77T

    ADRIATIC

    LAURA

    Special mentions


    For more episodes, resources and blog posts, visit www.inquisitiveonc.com

    Please find us on Twitter @InquisitiveOnc!

    If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


    Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have no editorial rights or early previews, and they have access to the episode at the same time you do.


    Art courtesy of Taryn Silver

    Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/

    Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.






    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about 134. ESMO 2024 - Lung Cancer with Dr Ned McNamee

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.